Assistant Professor of Medicine
Hematology
Dr. Dan T. Vogl, MD
|
|
Give Review
Vogl works in the field of Hematology. He researched medicine at Weill Cornell Medical College of Cornell University. Weill Cornell Medical College of Cornell University is ranked 18/49 in Research/PrimaryCare. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Vogl has written publications. He has 40 publications published with PubMed. The lastest paper is: 'Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapy.' He accepts Medicare.
Publications
- Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple Myeloma from chemotherapy.
- Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study.
- Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory Myeloma.
- NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in Myeloma.
- New Cancers after autotransplantations for multiple myeloma.
- Impact of Pre-transplant Therapy and Depth of Disease Response prior to Autologous Transplantation for Multiple Myeloma.
- Classifying ultra-high risk smoldering Myeloma.
- Melphalan/Total Body Irradiation-Conditioned Myeloablative Allogeneic Hematopoietic Cell Transplantation for Patients With Primary Plasma Cell Leukemia.
- Association between mobilization regimen and PFS after auto-SCT for multiple Myeloma.
- Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation.
- Combined autophagy and proteasome inhibition: A phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory Myeloma.
- Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autolo...
- Trimming the fat: obesity and hematopoietic cell transplantation.
- Cellular immunotherapy for plasma cell Myeloma.
- The evolving role of plerixafor in hematopoietic progenitor cell mobilization.
- Salvage Second Hematopoietic Cell Transplantation in Myeloma.
- Scleromyxedema and dermato???neuro syndrome in a patient with multiple Myeloma effectively treated with dexamethasone and bortezomib.
- Trends in allogeneic stem cell transplantation for multiple Myeloma: a Center for International Blood and Marrow Transplant Research (CIBMTR) analysis.
- Effect of Obesity on Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
- The presence of amyloid in abdominal and oral mucosal tissues in patients initially diagnosed with multiple Myeloma: a pilot study.
- Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for Myeloma.
- Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple Myeloma leads to reconstitution of influenza immunity...
- Crystal-storing histiocytosis in plasma cell Myeloma.
- A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory Acute myelogenous leukemia.
- Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis.
- A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 Acute myeloid leukemia.
- Hypertriglyceridemia presenting as "pink blood" and elevated hemoglobin level.
- Differentiation syndrome in non-M3 Acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene.
- Post-transplant outcomes of induction therapy for Myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphala...
- Medical management update: multiple Myeloma.
- Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation.
- Second auto-SCT is safe and effective salvage therapy for relapsed multiple Myeloma.
- Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple Myeloma (BMT CT...
- EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: results of a two-arm prospective trial.
- High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast Cancer: a therapy whose time has passed.
- Stem cell collection in patients with multiple Myeloma: impact of induction therapy and mobilization regimen.
- Successful treatment of T-cell post-transplant lymphoproliferative disorder with the retinoid analog bexarotene.
- Posttransplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen cases.
- Impact of prior therapies on the relative efficacy of bortezomib compared with dexamethasone in patients with relapsed/refractory multiple Myeloma.
Schools
Joan Sanford I Weill Medical College Of Cornell University
Ny and Presby Hospital
University Of Pa Health System
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Burkitt's Lymphoma
- Carcinoma in Situ
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Pennsylvania Health System -
New York Presbyterian Hospital -
Weill Cornell Medical College of Cornell University
Hospital
-
Hospital of the University of Pennsylvania -
Penn Presbyterian Medical Center
Drug Facts
| NPI NUMBER | 1992733448 | |
| NPPES Provider LastName | VOGL | |
| NPPES Provider FirstName | DAN | |
| NPPES Provider ZIPCode | 191045127 | |
| NPPES Provider State | PA | |
| Specialty Description | Hematology | |
| Total Claim Count | 1035.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 319.0 | |
| Percent Opioid Claims | 30.82 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1992733448 |
| Last Name Of The Provider | VOGL |
| First Name Of The Provider | DAN |
| View All |
Similar Doctors
|
|
Dr. Susan C. Weil, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah R. Goodyear, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William J. Tester, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunita Sheth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shannon R. McCurdy, MD |
|
|
Dr. Bruce J. Giantonio, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Atrayee Basu Mallick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rodwige J. Desnoyers, MD
This Doctor is OpenDoctor Recommended.
|